Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report
Hepatology Research · 2026-06 · 56 (6) · 1047-1052
DOI: 10.1111/hepr.70142 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hepatology Research, online erschienen am 24.02.2026. Verfasst von Etsuko Moriyama und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Kurume University.
Abstract (Originalsprache)
Background
Malignant hepatocellular neoplasm, not otherwise specified (HCN, NOS), is a rare primary liver tumor showing overlapping features of hepatoblastoma and hepatocellular carcinoma. Because of its rarity and histopathologic heterogeneity, the optimal treatment strategy for HCN, NOS remains undefined. Aim and Methods We report a case of a 20‐year‐old woman with initially unresectable HCN, NOS, who was treated with hepatic arterial infusion chemotherapy using a fine‐powder formulation of cisplatin suspended in Lipiodol combined with continuous 5‐fluorouracil administration (New FP). The therapeutic response was assessed radiologically and serologically after each treatment cycle, and the patient subsequently underwent surgical resection after adequate tumor regression.
Results
After eight cycles of New FP, marked tumor shrinkage and a significant decline in tumor markers were achieved, enabling subsequent systemic chemotherapy according to the SIOPEL‐4 regimen. Thereafter, conversion hepatectomy was performed, and histological examination of the resected specimen demonstrated approximately 90% tumor necrosis. The patient has remained disease‐free for 20 months after surgery.
Conclusion
This case demonstrates the potential of New FP as an effective hepatic arterial infusion regimen capable of achieving conversion therapy in rare liver malignancies such as HCN, NOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
- Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
- Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
- Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan.
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
ORCID-Profile: Hideki Iwamoto, Shigeo Shimose, Masahito Nakano, Masaki Honda, Taizo Hibi, Yoshiki Mikami, Takumi Kawaguchi
Förderung
- Kurume University
Zitieren
APA
Moriyama, E., Koga, H., Niizeki, T., Iwamoto, H., Shimose, S., Shirono, T., Tokushige, T., Nakano, M., Kuromatsu, R., Goto, T., Honda, M., Hibi, T., Mikami, Y., Kondo, R., Akiba, J., & Kawaguchi, T. (2026). Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report. Hepatology Research, 56(6), 1047-1052. https://doi.org/10.1111/hepr.70142
Vancouver
Moriyama E, Koga H, Niizeki T, Iwamoto H, Shimose S, Shirono T, et al. Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report. Hepatology Research. 2026;56(6):1047-1052. doi:10.1111/hepr.70142
BibTeX
@article{Moriyama2026,
author = {Moriyama, Etsuko and Koga, Hironori and Niizeki, Takashi and Iwamoto, Hideki and Shimose, Shigeo and Shirono, Tomotake and Tokushige, Takahiko and Nakano, Masahito and Kuromatsu, Ryoko and Goto, Toru and Honda, Masaki and Hibi, Taizo and Mikami, Yoshiki and Kondo, Reiichiro and Akiba, Jun and Kawaguchi, Takumi},
title = {Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {6},
pages = {1047--1052},
doi = {10.1111/hepr.70142}
}
EUVIMED